Verquvo (Vericiguat)

Verquvo (Vericiguat)

Verquvo

Vericiguat

Tablets: 2.5 mg, 5 mg and 10 mg

Merck

Medical Use

Verquvo is a soluble guanylate cyclase (sGC) stimulator used to treat adults with chronic heart failure who have symptoms or signs of the condition, have recently been hospitalized, or required intravenous (IV) medications, and have an ejection fraction (the percentage of blood pumped out with each heartbeat) of less than 45%. This medication helps reduce the risk of death and the need for hospitalization.

Recommended Dosage :

  • Starting Dose: Begin with 2.5 mg (one Verquvo tablet) once daily with food.
  • Dose Adjustment: Double the dose approximately every two weeks to reach the target maintenance dose of 10 mg once daily, as tolerated by the patient.

Administration :

  • Swallow the tablets whole. If you cannot swallow the tablet whole, you may crush it and mix it with water just before taking your dose.
  • If you miss a dose, take it as soon as possible on the same day. Do not take two doses on the same day to make up for a missed dose.